glutamic acid has been researched along with cp 96345 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuraishi, Y; Okano, K; Satoh, M | 1 |
| De Koninck, Y; Henry, JL; Salter, MW | 1 |
| Sluka, KA; Westlund, KN | 1 |
| Mitrovic, I; Napier, TC | 1 |
4 other study(ies) available for glutamic acid and cp 96345
| Article | Year |
|---|---|
Involvement of substance P and excitatory amino acids in aversive behavior elicited by intrathecal capsaicin.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Animals; Avoidance Learning; Biphenyl Compounds; Capsaicin; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Hypnotics and Sedatives; Injections, Spinal; Male; Nociceptors; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reinforcement, Psychology; Substance P; Synaptic Transmission | 1994 |
Substance P released endogenously by high-intensity sensory stimulation potentiates purinergic inhibition of nociceptive dorsal horn neurons induced by peripheral vibration.
Topics: Animals; Biphenyl Compounds; Caffeine; Cats; Electric Stimulation; Electrophysiology; Glutamic Acid; Hypnotics and Sedatives; Iontophoresis; Neurons; Peripheral Nerves; Skin; Spinal Cord; Substance P; Time Factors; Vibration | 1994 |
Spinal cord amino acid release and content in an arthritis model: the effects of pretreatment with non-NMDA, NMDA, and NK1 receptor antagonists.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Animals; Arthritis; Biphenyl Compounds; Disease Models, Animal; Glutamates; Glutamic Acid; Immunohistochemistry; Lidocaine; Male; Microdialysis; Neurokinin-1 Receptor Antagonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord | 1993 |
Substance P attenuates and DAMGO potentiates amygdala glutamatergic neurotransmission within the ventral pallidum.
Topics: Amygdala; Analgesics, Opioid; Animals; Biphenyl Compounds; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Evoked Potentials; Globus Pallidus; Glutamic Acid; Hypnotics and Sedatives; Male; Neurons; Neurotransmitter Agents; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reaction Time; Stimulation, Chemical; Substance P; Synaptic Transmission | 1998 |